Exenteration is a
radical surgical procedure that involves the removal of multiple pelvic organs or the contents of the orbit (
eye socket) in order to treat advanced or recurrent cancers. This complex
operation is typically performed when other treatment options, such as
radiation therapy or
chemotherapy, have been exhausted or deemed ineffective. The purpose of exenteration is to achieve local control of the cancer, alleviate symptoms, and potentially extend the patient’s life. This comprehensive guide will provide an overview of the different types of exenteration, the surgical techniques involved, and the recovery process, as well as address the physical, psychological, and ethical considerations associated with this
major procedure.
Pelvic exenteration is a type of exenteration that involves the removal of multiple pelvic organs, such as the
bladder,
rectum,
anus,
sigmoid colon,
seminal vesicles, and
reproductive organs (e.g.,
cervix,
womb,
ovaries), in order to treat advanced or recurrent pelvic cancers, particularly
cervical cancer[1].
Orbital exenteration is a type of exenteration that involves the removal of the entire contents of the orbit, including the
eyeball,
periorbita, and
appendages, in order to treat advanced or recurrent cancers of the eye or surrounding structures
[2].
Pelvic exenteration is a complex surgical procedure that involves the
en bloc resection of multiple pelvic organs, including the
bladder,
rectum,
anus,
sigmoid colon,
seminal vesicles, and
reproductive organs (e.g.,
cervix,
womb,
ovaries), in order to treat advanced or recurrent pelvic cancers, particularly
cervical cancer. The goal of the surgery is to achieve local control of the cancer, alleviate symptoms, and potentially extend the patient’s life
[1].
Pelvic exenteration was first described in 1948 by Alexander Brunschwig as a
palliative procedure for advanced cervical cancer. Over time, the technique has evolved and is now considered a potentially
curative treatment for selected patients with advanced or recurrent pelvic cancers
[1].
The primary indication for pelvic exenteration is advanced or recurrent pelvic cancer, particularly
cervical cancer, that has not responded to other treatments, such as
radiation therapy or
chemotherapy. Other potential candidates include patients with advanced or recurrent cancers of the
rectum,
bladder, or
vagina[1].
Before undergoing pelvic exenteration, patients undergo a thorough
preoperative evaluation, including
imaging studies (e.g.,
MRI,
CT,
PET) and
staging procedures (e.g.,
endorectal ultrasound,
biopsy), to assess the extent of the cancer and determine their eligibility for the procedure
[1].
Technique and Steps
Pelvic exenteration typically involves the following steps:
Laparotomy: The abdomen is opened through a large incision.
Retroperitoneal dissection: The organs and tissues behind the peritoneum are mobilized, and the
ureters and major
blood vessels (e.g.,
aorta,
inferior vena cava) are identified and protected.
En bloc resection: The affected organs are removed in a single block, which may include the
bladder,
rectum,
anus,
sigmoid colon,
seminal vesicles, and
reproductive organs (e.g.,
cervix,
womb,
ovaries).
Reconstruction: Depending on the extent of the resection, various reconstructive procedures may be performed, such as
urinary diversion (e.g.,
ileal conduit,
neobladder),
colostomy, or
vaginal reconstruction[1].
Immediately after pelvic exenteration, patients are closely monitored in the
intensive care unit (ICU) for potential complications, such as
bleeding,
infection, or
organ dysfunction. Pain management and wound care are also important aspects of postoperative care
[1].
Long-term Recovery
The long-term recovery process after pelvic exenteration can be challenging, both physically and emotionally. Patients may experience changes in
bowel,
bladder, and
sexual function, as well as altered body image and self-esteem.
Rehabilitation, counseling, and support groups can help patients adapt to these changes and improve their
quality of life[1].
Effective management of complications after pelvic exenteration requires close monitoring, prompt diagnosis, and appropriate intervention. This may involve
antibiotics for
infections,
blood transfusions for bleeding, or
surgical revision for anastomotic leaks or wound healing problems
[1].
Pelvic exenteration is most commonly performed for advanced or recurrent
cervical cancer that has not responded to other treatments, such as
radiation therapy or
chemotherapy. In carefully selected patients, pelvic exenteration can achieve local control of the cancer and potentially improve survival
[1].
Pelvic exenteration may also be considered for other advanced or recurrent pelvic cancers, such as cancers of the
rectum,
bladder, or
vagina, when other treatment options have been exhausted or deemed ineffective
[1].
One of the primary goals of pelvic exenteration is to alleviate symptoms associated with advanced or recurrent pelvic cancers, such as
pain,
bleeding, or
obstruction. In many cases, the procedure can effectively control these symptoms and improve the patient’s quality of life
[1].
Life Extension and Quality of Life
In carefully selected patients, pelvic exenteration can potentially extend life expectancy and improve quality of life by achieving local control of the cancer. However, the procedure is associated with significant morbidity and changes in bowel, bladder, and sexual function, which can impact the patient’s overall well-being
[1].
Survival Rates and Predictive Factors
Survival rates after pelvic exenteration vary depending on factors such as the type and stage of cancer, the extent of the surgery, and the patient’s overall health. Predictive factors for improved survival include
negative surgical margins,
absence of lymph node involvement, and
good performance status[1].
Orbital exenteration is a radical surgical procedure that involves the removal of the entire contents of the orbit, including the
eyeball,
periorbita, and
appendages, in order to treat advanced or recurrent cancers of the eye or surrounding structures. The goal of the surgery is to achieve local control of the cancer and potentially extend the patient’s life
[2].
